[Use of canrenoate potassium given orally in ascitogenic cirrhosis].
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D001201:Ascites / Q000188:drug therapy*; D002191:Canrenoic Acid / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008103:Liver Cirrhosis / Q000150:complications* / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D011188:Potassium / Q000378:metabolism; D011245:Pregnadienes / Q000627:therapeutic use*; D012964:Sodium / Q000378:metabolism
D011245:Pregnadienes; D002191:Canrenoic Acid; D012964:Sodium; D011188:Potassium
Uso del canrenoato di potassio per via orale nella cirrosi ascitogena.